Eli Lilly hits record high as healthcare stocks rally 

By Reuters News

** Shares of the world's largest drugmaker Eli Lilly LLY.N jump 5.45% to an all-time high of $1,307.91

** Stock's previous 52-week high was $1,292.65

** Wall Street coverage on the trillion-dollar stock tilts bullish with 29 analysts rating it "buy" or "strong buy", 3 rating "hold" and 1 "sell" with a median PT of $1,380.50, per LSEG data

** LLY has broadened its drug pipeline through a series of acquisitions and licensing deals, using the strong cash flow from its diabetes and weight-loss medicines to fuel a wider dealmaking push

** Other large-cap drugmakers including Amgen AMGN.O, Pfizer PFE.N, Johnson & Johnson JNJ.N and AbbVie ABBV.N were also up in morning trade, the broader S&P 500 Healthcare Index .SPXHC touched a record high

** Including session's move, LLY stock was up ~21% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.